<DOC>
	<DOC>NCT02388438</DOC>
	<brief_summary>This study evaluates the demineralized bone matrix in "Hallux valgus".</brief_summary>
	<brief_title>Demineralized Bone Matrix in Opening Wedge Osteotomy for Hallux Valgus Deformity</brief_title>
	<detailed_description>Demineralized bone matrix use for filling in the space removed bone in open wedge osteotomy and correction. The purpose this study is to test therapeutic benefits of demineralized bone matrix. Investigator will recruit thirty patients. Total evaluation period will be 12 months. In this period, investigator will examine correction rate, fusion rate, functional test, adverse event.</detailed_description>
	<mesh_term>Congenital Abnormalities</mesh_term>
	<mesh_term>Hallux Valgus</mesh_term>
	<criteria>(1) The patient ranging in age from 20 to 75 years (2) Has to be operated over 5mm osteotomy for correcting hallux valgus. (3) The patients who were able to comply with the research protocol. (1) Bursitis in metatarsal bones has affected surgery. (2) Has rheumatism (3) The patient who has clinical sign of infection on the operated site at prescreening (4) Patient who has failure of peripheral blood circulation caused by chronic disease and neurological symptoms (5) In the opinion of investigator, the patient is not suitable to participate in this study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>demineralized bone matrix</keyword>
</DOC>